Reconstruction of bisphenol A intake using a simple pharmacokinetic model

Journal of Exposure Science and Environmental Epidemiology

Volumn 25, Issue 3, 2015, Pages 240-248

  Christensen, Krista L Y ^a   Lorber, Matthew ^a   Ye, Xiaoyun ^b   Calafat, Antonia M ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

biomonitoring; BPA; exposure; metabolism; pharmacokinetic

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; PHENOL DERIVATIVE; POLLUTANT;

ADULT; ANALYSIS; BIOLOGICAL MODEL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; FOOD CONTAMINATION; HUMAN; MALE; MIDDLE AGED; NORMAL HUMAN; PHARMACOKINETICS; POLLUTANT; PROCEDURES; URINE;

ADULT; BENZHYDRYL COMPOUNDS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; FOOD CONTAMINATION; HEALTHY VOLUNTEERS; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PHENOLS;

EID: 84928587021     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/jes.2013.81     Document Type: Article

References (42)

1. EPA. Bisphenol A Action Plan. U.S. Environmental Protection Agency, Washington, DC, USA, 2010.
2. NTP-CERHR. NTP-CERHR Monograph on the Potent ial Human Reproductive and Developmental Effects of Bisphenol A. National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction, 2008 Contract No.: NIH Publication No. 08-5994, Research Triangle Park, NC.
3. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJR, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010; 118: 1055-1070.
4. Tsukioka T, Terasawa J, Sato S, Hatayama Y, Makino T, Nakazawa H. Development of analytical method for determining trace amounts of BPA in urine samples and estimation of exposure to BPA. J Environ Chem 2004; 14: 57-63.
5. Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 2002; 15: 1281-1287.
6. Volkel W, Bittner N, Dekant W. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatographytandem mass spectrometry. Drug Metab Dispos 2005; 33: 1748-1757.
7. WHO. Joint FAO/WHO Expert Meeting to Review Toxicological and Health Aspects of Bisphenol A: Summary Report including Report of Stakeholder Meeting on Bisphenol A. World Health Organization: Ottawa, Canada, 2010.
8. EU. European Union Risk Assessment Report: 4,40-ISOPROPYLIDENEDIPHENOL (BISPHENOL-A), CAS No: 80-05-7, EINECS No: 201-245-8. European Union: Luxembourg, 2003.
9. Miyamoto K, Kotake M. Estimation of daily bisphenol a intake of Japanese individuals with emphasis on uncertainty and variability. Environ Sci 2006; 13: 15-29.
10. Von Goetz N, Wormuth M, Scheringer M, Hungerbuhler K, Bisphenol A. How the most relevant exposure sources contribute to total consumer exposure. Risk Anal 2010; 30: 473-487.
11. Wilson NK, Chuang JC, Morgan MK, Lordo RA, Sheldon LS. An observational study of the potential exposures of preschool children to pentachlorophenol, bisphenol-A, and nonylphenol at home and daycare. Environ Res 2007; 103: 9-20.
12. Joskow R, Barr DB, Barr JR, Calafat AM, Needham LL, Rubin C. Exposure to bisphenol A from bis-glycidyl dimethacrylate-based dental sealants. J Am Dent Assoc 2006; 137: 353-362.
13. Geens T, Goeyens L, Kannan K, Neels H, Covaci A. Levels of bisphenol-A in thermal paper receipts from Belgium and estimation of human exposure. Sci Total Environ 2012; 435-436: 30-33.
14. Liao C, Kannan K. Widespread occurrence of bisphenol A in paper and paper products: implications for human exposure. Environ Sci Technol 2011; 45: 9372-9379.
15. Rudel RA, Brody JG, Spengler JD, Vallarino J, Geno PW, Sun G et al. Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. J Air Waste Manag Assoc 2001; 51: 499-513.
16. Rudel RA, Camann DE, Spengler JD, Korn LR, Brody JG. Phthalates, alkylphenols, pesticides, polybrominated diphenyl ethers, and other endocrine-disrupting compounds in indoor air and dust. Environ Sci Technol 2003; 37: 4543-4553.
17. Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 2009; 117: 639-644.
18. Vandentorren S, Zeman F, Morin L, Sarter H, Bidondo ML, Oleko A et al. Bisphenol-A and phthalates contamination of urine samples by catheters in the Elfe pilot study: implications for large-scale biomonitoring studies. Environ Res 2011; 111: 761-764.
19. Duty SM, Mendonca K, Hauser R, Calafat AM, Ye X, Meeker JD et al. Potential sources of bisphenol a in the neonatal intensive care unit. Pediatrics 2013; 131: 483-489.
20. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, Needham LL. Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 2005; 113: 391-395.
21. Lakind JS, Naiman DQ. Daily intake of bisphenol A and potential sources of exposure: 2005-2006 National Health and Nutrition Examination Survey. Journal of Exposure Science and Environmental Epidemiology 2011 21: 272-279.
22. CERHR. NTP-CERHR Expert Panel Report on the Reproductive and Developmental Toxicity of Bisphenol A.National Toxicology Program, U.S. Department of Health and Human Services: Research Triangle Park, NC 2007.
23. Koch HM, Kolossa-Gehring M, Schroter-Kermani C, Angerer J, Bruning T. Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: A retrospective exposure evaluation. J Expos Sci Environ Epidemiol 2012; 22: 610-616.
24. Wolff MS, Teitelbaum SL, Windham G, Pinney SM, Britton JA, Chelimo C et al. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect 2007; 115: 116-121.
25. Lorber M, Calafat AM. Dose reconstruction of di-2-ethylhexyl phthalate using a simple pharmacokinetic model (accepted for publication). Environ Health Perspect 2012; 120: 1705-1710.
26. NIH. National Center for Biotechnology Information. PubChem BioAssay Database; CID=16212886, Source=Scripps Research Institute Molecular Screening Center http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=16212886accessed on 3 December 2012.
27. Lorber M, Angerer J, Koch HM. A simple pharmacokinetic model to characterize exposure of Americans to di-2-ethylhexyl phthalate. J Expos Sci Environ Epidemiol 2010; 20: 38-53.
28. Crump KS, Gibbs JP. Benchmark calculations for perchlorate from three human cohorts. Environ Health Perspect 2005; 113: 1001-1008.
29. Pottenger LH, Domoradzki JY, Markham DA, Hansen SC, Cagen SZ, Waechter Jr JM. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol Sci 2000; 54: 3-18.
30. Preau JL, Wong LY, Silva MJ, Needham LL, Calafat AM. Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ Health Perspect 2010; 118: 1748-1754.
31. Ye XY, Wong LY, Bishop AM, Calafat AM. Variability of urinary concentrations of bisphenol a in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect 2011; 119: 983-988.
32. Li Z, Romanoff LC, Lewin MD, Porter EN, Trinidad DA, Needham LL et al. Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J Expos Sci Environ Epidemiol 2010; 20: 526-535.
33. Ye X, Kuklenyik Z, Needham LL, Calafat AM. Quantification of urinary conjugates of bisphenol A, 2,5-dichlorophenol, and 2-hydroxy-4-methoxybenzophenone in humans by online solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2005; 383: 638-644.
34. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod toxicol 2007 24: 139-177.
35. Kang JH, Kondo F, Katayama Y. Human exposure to bisphenol A. Toxicology 2006; 226: 79-89.
36. Verner MA, Magher T, Haddad S. High concentrations of commonly used drugs can inhibit the in vitro glucuronidation of bisphenol A and nonylphenol in rats. Xenobiotica 2010; 40: 83-92.
37. Fisher JW, Twaddle NC, Vanlandingham M, Doerge DR. Pharmacokinetic modeling: Prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans. Toxicol Appl Pharmacol 2011; 257: 122-136.
38. Shin BS, Hwang SW, Bulitta JB, Lee JB, Du Yang S, Park JS et al. Assessment of bisphenol a exposure in korean pregnant women by physiologically based pharmacokinetic modeling. J Toxicol Environ Health A 2010; 73: 1586-1598.
39. Teeguarden JG, Waechter JM, Clewell HJ, Covington TR, Barton HA. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 2005; 85: 823-838.
40. Volkel W, Kiranoglu M, Fromme H. Determination of free and total bisphenol A in urine of infants. Environ Res 2011; 111: 143-148.
41. Becker K, Goen T, Seiwert M, Conrad A, Pick-Fuss H, Muller J et al. GerES IV: phthalate metabolites and bisphenol A in urine of German children. Int J Hygiene Environ Health 2009; 212: 685-692.
42. NTP. NTP brief on bisphenol A [CAS No. 80-05-07]. In: NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. United States Department of Health and Human Services, National Toxicology Program: Research Triangle Park, NC, 2008.